Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125185465 | 12518546 | 5 | F | 20160819 | 20160630 | 20160824 | PER | US-TAKEDA-2016MPI005890 | TAKEDA | 0.00 | F | Y | 0.00000 | 20160824 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125185465 | 12518546 | 1 | PS | NINLARO | IXAZOMIB | 1 | Oral | 3 MG, QD | 1402445 | 208462 | 3 | MG | CAPSULE | QD | |||||
| 125185465 | 12518546 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 125185465 | 12518546 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125185465 | 12518546 | 1 | Plasma cell myeloma |
| 125185465 | 12518546 | 2 | Product used for unknown indication |
| 125185465 | 12518546 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125185465 | 12518546 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125185465 | 12518546 | Abnormal behaviour | |
| 125185465 | 12518546 | Asthenia | |
| 125185465 | 12518546 | Insomnia | |
| 125185465 | 12518546 | Malaise | |
| 125185465 | 12518546 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |